|
|||||
|
|||||
| Application number: | P200300500 | |
| Patent number: | 05272 | |
| PCT application number: | EP02/03668 | |
| Filing date of the application: | 03.04.2002 | |
| Publication date: | 15.12.2003 | |
| Date of the grant of the patent: | 15.02.2010 | |
| Priority date: | 12.04.2001 08.08.2001 | |
| Estonian title : | Merkaptoatsetüülamiidi derivaadid, nende valmistamismeetod ja kasutamine | |
| English title : | Mercaptoacetylamide derivatives, a process for their preparation and their use | |
| Status: | Invalid patent | |
| Fees paid for the years of validity : | 14 | |
| IPC class: | C07D471/04 A61K31/55 A61P9/04 | |
| CPC class: | ||
| Estonian abstract: | Leiutis käsitleb teatud tüüpi merkaptoatsetüülamiidi derivaate. Kirjeldatakse ka neid ühendeid sisaldavaid farmatseutilisi kompositsioone ning nende ühendite valmistamismeetodeid. Samuti kirjeldatakse nende ühendite kasutamist ravimi valmistamiseks kardiovaskulaarse haigusseisundi raviks. | |
| English abstract: | This invention discloses and claims a series of mercaptoacetylamide derivatives of formula (I). Also disclosed and claimed are pharmaceutical compositions incorporating these compounds and processes for preparing said compounds. The use of said compounds for inhibition of the enzymes angiotensin converting enzyme and neutral endopeptidase, and for the treatment of hypertension and congestive heart failure are also disclosed and claimed. | |
| Applicant/holder: |
Sanofi-Aventis Deutschland GmbH | |
| Inventor name: | Gary A. Flynn (US) Shujaath Mehdi (US) Jack Roger Koehl (US) Barbara Ann Anderson (US) Manfred Gerken (DE) Bernd Jablonka (DE) Heinz-Werner Kleemann (DE) Wolfgang Linz (DE) Werner Seiz (DE) Bernhard Seuring (DE) | |
| Drawing(s): Click on the drawing to display a larger drawing! |
||
| Published patent application: | Display the published patent application (Document A) | |
| Patent specification: | Display patent specification (Document B) | |
| Patent attorney: | Harald Tehver | |
| Display: | DATA OF THE FEES | |
|
